Granule protein changes and membrane receptor phenotype in maturing human eosinophils cultured from CD34+ progenitors
Article first published online: 8 MAY 2003
Clinical & Experimental Allergy
Volume 33, Issue 5, pages 640–648, May 2003
How to Cite
Al-Rabia, M. W., Blaylock, M. G., Sexton, D. W., Thomson, L. and Walsh, G. M. (2003), Granule protein changes and membrane receptor phenotype in maturing human eosinophils cultured from CD34+ progenitors. Clinical & Experimental Allergy, 33: 640–648. doi: 10.1046/j.1365-2222.2003.01639.x
- Issue published online: 8 MAY 2003
- Article first published online: 8 MAY 2003
- Submitted 4 September 2002; revised 4 December 2002; accepted 3 January 2003
- CD34+ progenitors;
- membrane receptor phenotype
Background Eosinophils are now recognized as major effector cells in allergic and asthmatic disease with a potent armoury of mediators whose release makes a major contribution to the inflammation underlying these conditions.
Objectives The purpose of this study was to compare cultured eosinophils (CE) with normal-density peripheral blood eosinophils (PBE) in terms of their membrane receptor expression and to analyse the expression and storage of the eosinophil granule proteins major basic protein (MBP) and eosinophil cationic protein (ECP) during eosinophil maturation in vitro.
Methods Purified human peripheral blood CD34+ cells were cultured in the presence of recombinant human IL-3, IL-5, rhGM-CSF, SCF, and FLT-3 ligand. PBE were isolated by density gradient centrifugation and negative immunomagnetic selection. Expression of CD11b, CD18, CD45, CD45RA, CD45RB, CD45RO, CD69, CD95, IL-5Rα, IL-9Rα, CCR1, CCR3, and CXCR4 by CE as they matured in culture were assessed by immunostaining and flow cytometry and expression of these receptors compared with freshly isolated PBE. Immunohistochemical staining and labophot-2TM light microscopy determined expression of MBP, ECP, and CD69 during eosinophil maturation.
Results Positive immunostaining for MBP and ECP was detectable in a proportion (15–20%) of CE as early as 3 days of culture even though these cells were mononuclear in appearance. The numbers of CE positive for both granule proteins increased in rhIL-3 and rhIL-5 treated cells to a maximum of ∼ 80% by day 28. Maturing eosinophils exhibited positive immunostaining for CD69 after 14, 21 and 28 days of culture. Compared with PBE, CE had lower expression of pan-CD45 and CD45 isoforms, CD95 and CD11b. In contrast, the specific mean fluorescence for CD69, CD18, IL-5Rα, and IL-9Rα was significantly elevated for CE compared with PBE. CCR3 expression by CE and PBE was similar with no expression of CXCR4 detected by either CE or PBE. No significant difference in expression of CCR1 was found between CE and PBE.
Conclusion These data suggest that CE and PBE share many phenotypic properties and both MBP and ECP appear early in eosinophil development in vitro. However, there are quantitative differences that may be a consequence of their immaturity and/or the influence of the cytokines used in their culture.